CINGWCingulate Inc.vs its industry peers
A metric-by-metric comparison of Cingulate Inc. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CINGWThis | $651853#7 | — | 0.0x#9 | — | — | -35.6%#11 | — | -119.0%#8 | — | — | -23.9%#3 | — |
| ERNAW | $58433#12 | 0.0x#3 | 0.0x#5 | 0.1x#4 | 755.9%#2 | 68.4%#2 | -1601.2%#8 | -205.3%#11 | -203.6%#3 | — | — | — |
| BFRGW | $2M#2 | — | 0.8x#13 | 17.8x#11 | — | 7.1%#7 | -5652.4%#10 | -259.9%#13 | — | — | -79.2%#11 | — |
| ATXI | $1M#3 | — | 1.1x#14 | 1.0x#6 | — | 75.0%#1 | -219.6%#3 | -242.8%#12 | — | — | -50.4%#8 | — |
| PTIX | $1M#4 | — | — | — | — | -10.5%#8 | — | — | — | — | -75.7%#10 | — |
| ELAB | $4M#1 | — | 0.3x#12 | 7.1x#10 | — | -24.0%#10 | -1304.4%#7 | -61.5%#4 | — | — | -99.5%#15 | — |
| VBIO | $976571#5 | — | 0.1x#11 | 1.3x#7 | -33.7%#6 | -57.0%#13 | -1012.6%#6 | -80.3%#6 | — | — | -91.6%#13 | — |
| KTTAW | $895507#6 | — | 0.0x#7 | 1.8x#8 | 3130.4%#1 | -46.9%#12 | -4286.7%#9 | -37.3%#3 | — | — | 12.1%#1 | — |
| BFRIW | $448117#8 | — | 0.1x#10 | 0.0x#3 | 11.7%#4 | 40.7%#4 | -27.2%#2 | -173.6%#10 | -23159.2%#5 | — | -63.0%#9 | — |
| SXTPW | $163546#9 | — | 0.0x#8 | 0.2x#5 | 65.5%#3 | 7.3%#6 | -771.6%#5 | -152.5%#9 | -167.4%#2 | 5#1 | 9.2%#2 | — |
| SBFMW | $160691#10 | 0.0x#4 | 0.0x#3 | 0.0x#2 | 4.1%#5 | -16.4%#9 | -17.2%#1 | -27.8%#1 | -162.1%#1 | — | -83.7%#12 | — |
| ASBPW | $29790#14 | 0.0x#2 | 0.0x#4 | 4.8x#9 | — | -1768.9%#16 | -312016.9%#11 | -632.8%#14 | — | — | -46.8%#7 | — |
| DRMAW | $72399#11 | — | 0.0x#6 | — | — | 38.5%#5 | — | -117.9%#7 | — | — | -24.7%#4 | — |
| CDTTW | $42282#13 | 0.0x#1 | 0.0x#1 | — | — | -120.3%#15 | — | -37.2%#2 | — | — | -45.5%#6 | — |
| REVBW | $24232#15 | — | 0.0x#2 | — | — | 40.7%#3 | — | -68.6%#5 | — | — | -43.6%#5 | — |
| CELUW | $11578#16 | — | — | 0.0x#1 | -51.0%#7 | -58.4%#14 | -230.9%#4 | — | -398.1%#4 | — | -99.0%#14 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-08-02.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice